New drug introduced to check cholesterol

He said Ezetimibe also cuts down the cost of treatment. Hundreds of millions of people all over the world have been benefiting from this strategy.

However, a recent trial called ‘ENHANCE’ has triggered of controversy by showing that this combination is not superior to the use of Stsatins alone.

He said that a big debate on the issue is in the medical circles these days. This suggests that lowering of LDL may not be the only factor in cardiovascular risk protection. Statins may have some other, as yet unclear mechanism(s) of action, which prevent arterial occlusion, and prolongs life.

According to him new trials are underway to clarify the clinical benefits of Ezetimibe. Until the results of these studies are available in three to four years time, Statins remain the cornerstone of cholesterol management for the prevention of heart attacks and strokes.

The CME program of Ziauddin Medical University was attended by the family physicians, postgraduate medical residents and other doctors.